Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
12/22/1994 | WO1994025056A3 Use of platelet-derived growth factor to improve collateral circulation |
12/22/1994 | WO1994017773A3 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
12/22/1994 | CA2566543A1 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia |
12/22/1994 | CA2164639A1 A novel use of ambasilide |
12/22/1994 | CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
12/22/1994 | CA2164583A1 Imidazole 5-position substituted angiotensin ii antagonists |
12/22/1994 | CA2164317A1 Use of natural products and related synthetic compounds for the treatment of cardiovascular disease |
12/22/1994 | CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists |
12/22/1994 | CA2163121A1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
12/22/1994 | CA2163018A1 N-[[1-[4-(4-fluorophenoxy)butyl] -4-piperidinyl]-n-methylamino]-2-benzothiazolols as class iii antiarrhythmic agents |
12/22/1994 | CA2161325A1 Pyrimidine, cyanoguandines as k-channel blockers |
12/22/1994 | CA2140660A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
12/22/1994 | CA2126166A1 Substituted monopyridylmethyl and bipyridylmethyl derivatives |
12/21/1994 | EP0629635A1 New 19-nor 11-beta-phenoxysulfonamide or 11-beta-phenoxyalkylsulfonylurea steriod derivatives, a process and intermediates for their production and their use as medicaments and pharmaceuticals containing them |
12/21/1994 | EP0629627A2 Bicyclic carboxylic acids and their derivatives as nep and aca inhibitors |
12/21/1994 | EP0629408A1 Combination of angiotensin converting enzyme inhibitors and AII antagonists |
12/21/1994 | EP0629407A2 Use of human protein C for prevention and treatment of depositions of thrombocytes |
12/21/1994 | EP0629406A1 Medicament for the treatment of sepsis or septic shock |
12/21/1994 | EP0629401A1 Use of 1,2,4-dithiazolium salts as chemotherapeutics, particularly as TNF-inhibitors, and now 1,2,4-dithiazolium salts |
12/21/1994 | EP0629199A1 Indole derivatives as 5-ht1 agonists |
12/21/1994 | EP0629198A1 Nitrogen containing heterocyclic compounds useful as pharmaceuticals |
12/21/1994 | EP0629190A1 Compounds as calcium channel antagonists |
12/21/1994 | CN1096513A Endothelin receptor antagonists |
12/21/1994 | CN1096443A Anti-atherosclerotic use of 17 alpha-dihydroeoquilin |
12/21/1994 | CN1027068C Alpha-substituted 4-(quinolin-2-yl-methoxy)-phenylacetic acide and-esters |
12/21/1994 | CN1027066C Method for manufacturing of novel indole derivative |
12/20/1994 | US5374731 Amino acid derivatives with renin-inhibiting properties, a process for the preparation thereof, agents containing these, and the use thereof |
12/20/1994 | US5374710 Compounds which release nitric oxide upon illumination |
12/20/1994 | US5374647 Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides |
12/20/1994 | US5374643 Antiischemic agents |
12/20/1994 | US5374640 Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides |
12/20/1994 | US5374629 Vitamin D analogues |
12/20/1994 | US5374621 Neurotensin method for inhibiting vascular leakage |
12/20/1994 | US5374618 Calcitonin peptides, and gene related pharmaceutical compositions |
12/20/1994 | CA1333603C Sulfamoyl-2-benzofurancarboxylic acid derivative |
12/18/1994 | CA2126158A1 19-nor steroids phenoxyalkylsulfonamide or phenoxyalkylsulfonylurea chain on 11 beta position, process and intermediates for their preparation, application as medicaments and pharmaceutical compositions containing them |
12/15/1994 | CA2124912A1 Therapeutic composition |
12/14/1994 | EP0628569A1 Triterpene derivatives and endothelin-receptor antagonists containing the same |
12/14/1994 | EP0628557A1 Biphenylmethane derivatives, the use of them and pharmacological compositions containing same |
12/14/1994 | EP0628556A1 Imidazopyridines |
12/14/1994 | EP0628543A1 Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, as well as a medicament containing them |
12/14/1994 | EP0628538A1 Process for the acylation of threonine derivatives and their use in the preparation of 1,4-dihydropyridines |
12/14/1994 | EP0628313A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists |
12/14/1994 | EP0628052A1 Alkali metal 8,9-dehydroestrone sulfate esters |
12/14/1994 | EP0628046A1 Triazolopyrimidin derivatives as antiotensin ii receptor antagonists |
12/14/1994 | EP0628045A1 Pyrazolopyrimidin derivatives as angiotensin ii receptor antagonists |
12/14/1994 | EP0628042A1 Serotoninergic ergoline derivatives |
12/14/1994 | EP0628032A1 Quinazolinone antianginal agents |
12/14/1994 | EP0627921A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
12/14/1994 | EP0543864B1 Novel vitamin d analogues |
12/14/1994 | EP0101681B1 Antibody to a mediator activity composition and its use in a pharmaceutical composition |
12/14/1994 | CN1096197A Compositions containing esters of unsaturated fatty acids |
12/13/1994 | US5373024 3,5-Substituted benzoylguanidines, process for their preparation, their use as a medicament of diagnostic and medicament containing them |
12/13/1994 | US5373023 Antiischaemic agent |
12/13/1994 | US5373017 Renin inhibitor |
12/13/1994 | US5373015 Treating hypertension and congestive heart failure |
12/13/1994 | US5373012 Useful in treatment of hair growth and cardiovascular disorder |
12/13/1994 | US5372999 Reduces low density liprotein bound peroxides and for prophylaxis of atheromatosis and angiophatic disorders caused by absence of hypercholesteraemia or hyperlipidaemia |
12/13/1994 | CA1333485C Fused benzazepines |
12/11/1994 | CA2125458A1 Pyrimidine compounds and their use as pharmaceuticals |
12/08/1994 | WO1994028132A2 Opioid receptors: compositions and methods |
12/08/1994 | WO1994028014A2 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | WO1994028013A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
12/08/1994 | WO1994027998A1 Psoralen®* derivatives, their preparation and use |
12/08/1994 | WO1994027994A1 Piperidine derivatives, their preparation and use |
12/08/1994 | WO1994027987A1 5-ht4 receptor antagonists |
12/08/1994 | WO1994027979A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
12/08/1994 | WO1994027971A1 Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines |
12/08/1994 | WO1994027967A1 Novel compounds |
12/08/1994 | WO1994027965A1 Novel 1-phenylalkanone 5-ht4 receptor ligands |
12/08/1994 | WO1994027964A1 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists |
12/08/1994 | WO1994027957A1 Compounds which release nitric oxide |
12/08/1994 | WO1994027631A1 Modified factor vii |
12/08/1994 | WO1994027621A1 Iron-binding polymers for oral administration |
12/08/1994 | WO1994027605A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
12/08/1994 | WO1994027591A1 Therapeutic substituted guanidines |
12/08/1994 | WO1994027580A1 Reduction of liposome-induced adverse physiological reactions |
12/08/1994 | WO1994012165A3 Enzyme inhibitors |
12/08/1994 | CA2163867A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
12/08/1994 | CA2163741A1 Peptide inhibitors of urokinase receptor activity |
12/08/1994 | CA2163372A1 5-ht4 receptor antagonists |
12/08/1994 | CA2163350A1 Opioid receptors: compositions and methods |
12/08/1994 | CA2162726A1 Modified factor vii |
12/08/1994 | CA2162610A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
12/08/1994 | CA2160118A1 Reduction of liposome-induced adverse physiological reactions |
12/08/1994 | CA2125077A1 Imidazopyridine |
12/07/1994 | EP0627413A1 Substituted benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them |
12/07/1994 | EP0626969A1 CoA-IT AND PAF INHIBITORS |
12/07/1994 | EP0626963A1 Vinylene-azaindole derivatives and process for their preparation |
12/07/1994 | EP0626960A1 Quinuclidine derivatives as squalene synthase inhibitors |
12/07/1994 | EP0626959A1 Benzopyran class iii antiarrhythmic agents |
12/07/1994 | EP0626955A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
12/07/1994 | EP0626954A1 Benzocycloheptenes, benzoxepines and benzothiepines |
12/07/1994 | EP0626952A1 Hypolipidaemic benzothiazepine compounds |
12/07/1994 | EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
12/07/1994 | EP0626859A1 Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
12/07/1994 | CN1026892C New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same |
12/06/1994 | US5371226 2-oxoquinoline derivatives |
12/06/1994 | US5371186 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock |
12/06/1994 | US5371094 Azaheterocyclylmethyl-chromans for treating axiety |